SC 13G

Company

Crinetics Pharmaceuticals, Inc.

Filed

July 26, 2018

Accession Number

0001615774-18-006903

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →